Insights

Loading spinner
Gathering insights about Sea Pharmaceuticals

Sea Pharmaceuticals Tech Stack

Sea Pharmaceuticals uses 8 technology products and services including Open Graph, Wix, Sentry, and more. Explore Sea Pharmaceuticals's tech stack below.

  • Open Graph
    Content Management System
  • Wix
    Content Management System
  • Sentry
    Issue Trackers
  • React
    Javascript Frameworks
  • JSON-LD
    Javascript Frameworks
  • Polyfill
    Javascript Libraries
  • Priority Hints
    Performance
  • Bootstrap
    UI Frameworks

Media & News

Sea Pharmaceuticals's Email Address Formats

Sea Pharmaceuticals uses at least 1 format(s):
Sea Pharmaceuticals Email FormatsExamplePercentage
FLast@seapharmaceuticals.comJDoe@seapharmaceuticals.com
29%
FirstLast@seapharmaceuticals.comJohnDoe@seapharmaceuticals.com
21%
FLast@seapharmaceuticals.comJDoe@seapharmaceuticals.com
29%
FirstLast@seapharmaceuticals.comJohnDoe@seapharmaceuticals.com
21%

Frequently Asked Questions

What is Sea Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Sea Pharmaceuticals's official website is seapharmaceuticals.com and has social profiles on LinkedInCrunchbase.

What is Sea Pharmaceuticals's NAICS code?

Minus sign iconPlus sign icon
Sea Pharmaceuticals's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Sea Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of December 2025, Sea Pharmaceuticals has approximately 9 employees across 3 continents, including North AmericaAfricaAsia. Key team members include President, Ceo, Chief Science Officer (cso), Founder, Director (biologist And Pharmacologist): J. P. P.V.P. Of Chemistry: E. M.. Explore Sea Pharmaceuticals's employee directory with LeadIQ.

What industry does Sea Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Sea Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Sea Pharmaceuticals use?

Minus sign iconPlus sign icon
Sea Pharmaceuticals's tech stack includes Open GraphWixSentryReactJSON-LDPolyfillPriority HintsBootstrap.

What is Sea Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Sea Pharmaceuticals's email format typically follows the pattern of FLast@seapharmaceuticals.com. Find more Sea Pharmaceuticals email formats with LeadIQ.

How much funding has Sea Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of December 2025, Sea Pharmaceuticals has raised $417K in funding. The last funding round occurred on Feb 10, 2025 for $417K.

When was Sea Pharmaceuticals founded?

Minus sign iconPlus sign icon
Sea Pharmaceuticals was founded in 2013.

Sea Pharmaceuticals

Pharmaceutical ManufacturingMassachusetts, United States2-10 Employees

Privately held neurotherapeutics company founded in March 2013 by J.P. Pearson and E.J. Martinez and operated in Cambridge Massachusetts USA. Sea Pharmaceuticals LLC conducts research, development, and-commercialization (R-&-D-&-C) of Sea's novel proprietary synthetic small molecules targeting glutamate neurotransmitter system in neurology disorders. Sea is advancing orally administered potential treatments for high need constant bothersome tinnitus (CBT), Epilepsy, and sporadic Amyotrophic Lateral Sclerosis (S-ALS). Sea has 1 emeritus board member EBM & 7 board members. Benjamin F Cravatt PhD is Sea’s emeritus board member. Ben is neurochemist/ biologist Professor Scripps Research Institute and member NAS (USA National Academy Sciences); Ben founded >10 biotech co’s ActivX, Abide / Lundbeck, Vividion /Bayer, et al.; Sea's 7 board members: (i) Eric R Olson PhD molecular biologist, pharmacologist, trustee Cystic Fibrosis Foundation CFF; drug maker led R-&-D-&-C at Vertex VRTX to 4 life-saving CF drugs Kalydeco, Orkambi, Symdeco, Trikafta; former Aurora/ Vertex, Syros, Upjohn, Warner-Lambert/ Parke-Davis; (ii) Mark G Currie PhD molecular pharmacologist; on board IRWD; former CSO, President Ironwood Pharma Inc; Cyclerion Inc, Sepracor, Monsanto; Mark led R-&-D-&-C teams to drugs Celebrex, Bextra, Deramaxx (veterinary), Dynastat (Europe/Asia), Lunesta, Xopenex, Linzess / Constella (EU); (iii) W. Kendall Brown JD Cal-Tech trained physicist; lawyer Brown Associates Des Moines Iowa; computer scientist Advanced Logic Systems; IBM, California, (iv) Michael J Higgins MBA on several boards; was COO CFO Ironwood / Microbia; VP Genzyme, VP Procept); (v) Shaker Sadasivam PhD, MBA engineer formerly CEO Sun Edison Semi -Conductor (SEMI) Monsanto; on boards several co.; (vi) Nabil Elkouh PhD engineer, metals / batteries expert, CEO Conamix; Erigo Tech LLC, American Titanium Works (ATW); (vii) James P Pearson, President & CEO, Sea. See more at https://www.seapharmaceuticals.com

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2013
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $417K

    Sea Pharmaceuticals has raised a total of $417K of funding over 3 rounds. Their latest funding round was raised on Feb 10, 2025 in the amount of $417K.

  • $1M$10M

    Sea Pharmaceuticals's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $417K

    Sea Pharmaceuticals has raised a total of $417K of funding over 3 rounds. Their latest funding round was raised on Feb 10, 2025 in the amount of $417K.

  • $1M$10M

    Sea Pharmaceuticals's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.